888. In Vitro Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence

BACKGROUND: The integrase strand transfer inhibitor (INSTI)-based regimens bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF), dolutegravir (DTG)+FTC/TAF, DTG/lamivudine (3TC), and DTG/rilpivirine (RPV) are all used for treatment of HIV-infected patients. Here, relative time to in vitro v...

Descripción completa

Detalles Bibliográficos
Autores principales: Acosta, Rima K, Mulato, Andrew, D’Antoni, Michelle L, Yant, Stephen R, Cihlar, Tomas, White, Kirsten L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644010/
http://dx.doi.org/10.1093/ofid/ofab466.1083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644010/
http://dx.doi.org/10.1093/ofid/ofab466.1083

Ejemplares similares